ANO1 and breast carcinoma: Anoctamin1 (ANO1) is a calcium-activated chloride channel (CaCC) that is widely expressed in a variety of human carcinomas, including head and neck squamous cell carcinoma, esophageal squamous cell carcinoma, oral cancer, breast cancer, and prostate cancer17–22.